170 related articles for article (PubMed ID: 9170165)
1. Sequence analysis of the human tyrosinase promoter from a patient with tyrosinase-negative oculocutaneous albinism.
Matsunaga J; Dakeishi M; Miyamura Y; Tomita Y
Pigment Cell Res; 1997; 10(1-2):64-7. PubMed ID: 9170165
[TBL] [Abstract][Full Text] [Related]
2. Mutations of the tyrosinase gene in oculocutaneous albinism.
Shibahara S
Pigment Cell Res; 1992 Nov; 5(5 Pt 2):279-83. PubMed ID: 1292010
[TBL] [Abstract][Full Text] [Related]
3. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
Nakamura E; Miyamura Y; Matsunaga J; Kano Y; Dakeishi-Hara M; Tanita M; Kono M; Tomita Y
J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism.
Oetting WS; Handoko HY; Mentink MM; Paller AS; White JG; King RA
J Invest Dermatol; 1991 Jul; 97(1):15-9. PubMed ID: 1676041
[TBL] [Abstract][Full Text] [Related]
5. Tyrosinase gene mutations causing oculocutaneous albinisms.
Tomita Y
J Invest Dermatol; 1993 Feb; 100(2 Suppl):186S-190S. PubMed ID: 8433007
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of tyrosinase-negative oculocutaneous albinism. A single base mutation in the tyrosinase gene causing arginine to glutamine substitution at position 59.
Takeda A; Tomita Y; Matsunaga J; Tagami H; Shibahara S
J Biol Chem; 1990 Oct; 265(29):17792-7. PubMed ID: 2120217
[TBL] [Abstract][Full Text] [Related]
7. Molecular bases of tyrosinase-negative oculocutaneous albinism: a single base insertion or a missense point mutation in the tyrosinase gene.
Tomita Y; Takeda A; Matsunaga J; Okinaga S; Shibahara S; Tagami H
Pigment Cell Res; 1992; Suppl 2():96-100. PubMed ID: 1409445
[TBL] [Abstract][Full Text] [Related]
8. Prevalent and novel mutations of the tyrosinase gene in Korean patients with tyrosinase-deficient oculocutaneous albinism.
Park SK; Lee KH; Park KC; Lee JS; Spritz RA; Lee ST
Mol Cells; 1997 Apr; 7(2):187-91. PubMed ID: 9163730
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism.
King RA; Oetting WS
Pigment Cell Res; 1992; Suppl 2():249-53. PubMed ID: 1409426
[TBL] [Abstract][Full Text] [Related]
10. Sequence-based diagnosis of tyrosinase-related oculocutaneous albinism: successful sequence analysis of the tyrosinase gene from blood spots dried on filter paper.
Matsunaga J; Dakeishi-Hara M; Miyamura Y; Nakamura E; Tanita M; Satomura K; Tomita Y
Dermatology; 1998; 196(2):189-93. PubMed ID: 9568405
[TBL] [Abstract][Full Text] [Related]
11. Electron microscopic DOPA reaction test for oculocutaneous albinism.
Takizawa Y; Kato S; Matsunaga J; Aozaki R; Tomita Y; Nishikawa T; Shimizu H
Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
Oetting WS; King RA
Hum Mutat; 1993; 2(1):1-6. PubMed ID: 8477259
[TBL] [Abstract][Full Text] [Related]
13. Mutations of the tyrosinase gene in Indo-Pakistani patients with type I (tyrosinase-deficient) oculocutaneous albinism (OCA).
Tripathi RK; Bundey S; Musarella MA; Droetto S; Strunk KM; Holmes SA; Spritz RA
Am J Hum Genet; 1993 Dec; 53(6):1173-9. PubMed ID: 7902671
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic sequences of the tyrosinase gene: allele analysis on 16 OCA1 patients in Japan indicate that three polymorphic sequences in the tyrosinase gene promoter could be powerful markers for indirect gene diagnosis.
Tanita M; Matsunaga J; Miyamura Y; Dakeishi M; Nakamura E; Kono M; Shimizu H; Tagami H; Tomita Y
J Hum Genet; 2002; 47(1):1-6. PubMed ID: 11829136
[TBL] [Abstract][Full Text] [Related]
15. [Human oculocutaneous albinism. From clinical observation to molecular biology].
Aquaron R
Bull Soc Pathol Exot; 1993; 86(5):313-26. PubMed ID: 8124097
[TBL] [Abstract][Full Text] [Related]
16. R278TER and P431L mutations of the tyrosinase gene exist in Japanese patients with tyrosinase-negative oculocutaneous albinism.
Matsunaga J; Dakeishi M; Shimizu H; Tomita Y
J Dermatol Sci; 1996 Nov; 13(2):134-9. PubMed ID: 8953413
[TBL] [Abstract][Full Text] [Related]
17. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions.
Tripathi RK; Strunk KM; Giebel LB; Weleber RG; Spritz RA
Am J Med Genet; 1992 Jul; 43(5):865-71. PubMed ID: 1642278
[TBL] [Abstract][Full Text] [Related]
18. Cloning and sequence analysis of the tyrosinase gene from a patient with tyrosinase-positive oculocutaneous albinism.
Matsunaga J; Takeda A; Tomita Y; Hara M; Shibahara S; Tagami H
J Dermatol Sci; 1992 May; 3(3):181-5. PubMed ID: 1498098
[TBL] [Abstract][Full Text] [Related]
19. A dinucleotide deletion (-delta GA115) in the tyrosinase gene responsible for type I-A (tyrosinase negative) oculocutaneous albinism in a Pakistani individual.
Oetting WS; Fryer JP; King RA
Hum Mol Genet; 1993 Jul; 2(7):1047-8. PubMed ID: 8364542
[No Abstract] [Full Text] [Related]
20. Tyrosinase gene mutations associated with type IB ("yellow") oculocutaneous albinism.
Giebel LB; Tripathi RK; Strunk KM; Hanifin JM; Jackson CE; King RA; Spritz RA
Am J Hum Genet; 1991 Jun; 48(6):1159-67. PubMed ID: 1903591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
